These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2213055)

  • 1. Combined neuroleptic malignant syndrome and the central anticholinergic syndrome.
    Bennett DA
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):711. PubMed ID: 2213055
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hypomania following neuroleptic malignant syndrome.
    Steadman P
    Biol Psychiatry; 1992 Jul; 32(1):104-5. PubMed ID: 1391291
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of neuroleptic malignant syndrome and serotonin disturbance.
    Young C
    J Clin Psychopharmacol; 1997 Feb; 17(1):65-6. PubMed ID: 9004069
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome resulting from a complex drug-drug interaction: "I don't see 'em!".
    Preskorn SH
    J Psychiatr Pract; 2007 Sep; 13(5):328-33. PubMed ID: 17890981
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
    Khan A; Jaffe JH; Nelson WH; Morrison B
    J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 7. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes.
    Choi-Kain LW; Pope HG
    Harv Rev Psychiatry; 2007; 15(4):181-6. PubMed ID: 17687712
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for neuroleptic malignant syndrome.
    Akpaffiong MJ
    J Natl Med Assoc; 1992 Sep; 84(9):800-2. PubMed ID: 1404479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMS complicated by diazepam.
    Velamoor VR
    Br J Psychiatry; 1992 Jan; 160():135-6. PubMed ID: 1544009
    [No Abstract]   [Full Text] [Related]  

  • 10. Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome.
    Slack T; Stoudemire A
    Gen Hosp Psychiatry; 1989 Sep; 11(5):365-7. PubMed ID: 2507394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
    Marshall PB; Mellman TA; Nguyen SX
    Am J Psychiatry; 2008 Nov; 165(11):1488-9. PubMed ID: 18981078
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma.
    Balzan M; Cacciottolo JM
    Br J Psychiatry; 1992 Aug; 161():257-8. PubMed ID: 1521110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral neuropathy as a complication of neuroleptic malignant syndrome.
    Roffe C; Patel V; Abbott RJ; Czapla K
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):378-9. PubMed ID: 1647446
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome and lithium carbonate.
    Fava S; Galizia AC
    J Psychiatry Neurosci; 1995 Jul; 20(4):305-6. PubMed ID: 7647084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
    Tadke RR; Suryavanshi P
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):131-2. PubMed ID: 16525085
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome with hypomania and mental retardation.
    Ward MR; Corbett JA
    J Ment Defic Res; 1989 Aug; 33 ( Pt 4)():339-42. PubMed ID: 2769743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic toxicity masquerading as neuroleptic malignant syndrome: a case report and review.
    Catterson ML; Martin RL
    Ann Clin Psychiatry; 1994 Dec; 6(4):267-9. PubMed ID: 7647837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome in the intensive care unit.
    Sing RF; Branas CC; Marino PL
    J Am Osteopath Assoc; 1993 May; 93(5):615-8. PubMed ID: 8314724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New data on lithium and haloperidol incompatibility.
    Spring G; Frankel M
    Am J Psychiatry; 1981 Jun; 138(6):818-21. PubMed ID: 6113770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.